Notice2024-13338
Foreign-Trade Zone (FTZ) 22, Notification of Proposed Production Activity; AbbVie, Inc.; (Pharmaceutical Products); North Chicago, Illinois
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 18, 2024
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 118 (Tuesday, June 18, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 118 (Tuesday, June 18, 2024)]
[Notices]
[Page 51495]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-13338]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-32-2024]
Foreign-Trade Zone (FTZ) 22, Notification of Proposed Production
Activity; AbbVie, Inc.; (Pharmaceutical Products); North Chicago,
Illinois
AbbVie, Inc. submitted a notification of proposed production
activity to the FTZ Board (the Board) for its facilities in North
Chicago, Illinois within Subzone 22S. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on May 31, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material/component described in
the submitted notification (summarized below) and subsequently
authorized by the Board. The benefits that may stem from conducting
production activity under FTZ procedures are explained in the
background section of the Board's website--accessible via
<a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed material/component would be added to
the production authority that the Board previously approved for the
operation, as reflected on the Board's website.
The proposed foreign-status material/component is 2-Bromo-5-tosyl-
5H-pyrrolo[2,3-b]pyrazine (duty rate is 6.5%). The request indicates
the material/component is subject to duties under section 301 of the
Trade Act of 1974 (section 301), depending on the country of origin.
The applicable section 301 decisions require subject merchandise to be
admitted to FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#325446487246405356571c555d44"><span class="__cf_email__" data-cfemail="7b1d0f013b0f091a1f1e551c140d">[email protected]</span></a>. The closing period for their receipt is July 29, 2024.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Juanita Chen at
<a href="/cdn-cgi/l/email-protection#ec86998d8285988dc28f848982ac989e8d8889c28b839a"><span class="__cf_email__" data-cfemail="caa0bfaba4a3beabe4a9a2afa48abeb8abaeafe4ada5bc">[email protected]</span></a>.
Dated: June 12, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-13338 Filed 6-17-24; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 18, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.